Insulet
PODD
#2099
Rank
NZ$16.71 B
Marketcap
NZ$241.06
Share price
0.60%
Change (1 day)
-56.94%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): NZ$0.96 Billion

According to Insulet's latest financial reports the company's current earnings are NZ$3.05 Billion. In 2025 the company made an earning of NZ$0.71 Billion, an increase over its 2024 earnings that were of NZ$0.61 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.96 B35.25%
2025 NZ$0.71 B16.3%
2024 NZ$0.61 B36.76%
2023 NZ$0.44 B481.9%
2022 NZ$76.79 M-45.24%
2021 NZ$0.14 B43.35%
2020 NZ$97.82 M18.51%
2019 NZ$82.55 M41.16%
2018 NZ$58.48 M-711.95%
2017 -NZ$9.56 Million-56.85%
2016 -NZ$22.15 Million-79.31%
2015 -NZ$0.11 Billion63.85%
2014 -NZ$65.35 Million31.04%
2013 -NZ$49.87 Million-21.96%
2012 -NZ$63.91 Million
2010 -NZ$60.95 Million-42.38%
2009 -NZ$0.11 Billion-33.56%
2008 -NZ$0.16 Billion65.93%
2007 -NZ$95.95 Million209.75%
2006 -NZ$30.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.70 B 4,635.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$14.49 B 1,370.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$13.05 B 1,224.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$59.86 B 5,970.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-NZ$0.11 Billion-111.02%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$0.14 B-85.03%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$2.30 B 134.01%๐Ÿ‡บ๐Ÿ‡ธ USA